TIMP3 and cervical carcinoma: Compared with CC, patients with cervical cancer carrying genotypes CT/TT in TIMP-3 rs9862 had a higher risk of developing moderate and poor cell grading (grade 2/3, OR: 3.61, 95% CI: 1.14-12.01, p=0.012; Table 3).